Étude de l’association entre la rétinopathie diabétique et un polymorphisme du gène de l’aldose réductase dans la population tunisienne

[1]  S. Ayed,et al.  Iconography : Rétinopathie diabétique concomitante du diagnostic de diabète de type I , 2003 .

[2]  M. Ng,et al.  Phenotypic Heterogeneity and Associations of Two Aldose Reductase Gene Polymorphisms With Nephropathy and Retinopathy in Type 2 Diabetes , 2003 .

[3]  T. Sharma,et al.  Z–2 aldose reductase allele and diabetic retinopathy in India , 2003, Ophthalmic genetics.

[4]  C. Ahn,et al.  (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. , 2002, Diabetes research and clinical practice.

[5]  K. Lam,et al.  Diabetic nephropathy is associated with the 5¢‐end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[6]  R. Larkins,et al.  Aldose reductase (AC)(n) microsatellite polymorphism and diabetic microvascular complications in Caucasian Type 1 diabetes mellitus. , 2001, Diabetes research and clinical practice.

[7]  A. Demaine,et al.  Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus. , 2000, Investigative ophthalmology & visual science.

[8]  I. Makino,et al.  Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. , 2000, Diabetes research and clinical practice.

[9]  A. Kaider,et al.  ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. , 1999, Diabetes care.

[10]  K. Yamada,et al.  Association of an (A–C)n dinucleotide repeat polymorphic marker at the 5′‐region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[11]  K. Donaghue,et al.  A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. , 1999, Diabetes.

[12]  W. Knowler,et al.  Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 Diabetes , 1997, Diabetes Care.

[13]  M. Hibberd,et al.  Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated With the Development of Diabetic Nephropathy in Type I Diabetes , 1997, Diabetes.

[14]  K. Lam,et al.  An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. , 1995, Diabetes.

[15]  A. Markham,et al.  The human aldose reductase gene maps to chromosome region 7q35 , 1991, Human Genetics.

[16]  Y. Akagi,et al.  Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. , 1990, Archives of ophthalmology.

[17]  D. Dvornik.  Aldose Reductase Inhibition: An Approach to the Prevention of Diabetic Complications , 1987 .

[18]  A. Grímaldi,et al.  [Role of the polyol pathway in the occurrence of degenerative complications of diabetes]. , 1986, Presse medicale.

[19]  E. Friedman.  Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. , 1999, Diabetes care.